All are welcome.
Here are some of Outro’s core tasks, missions and objectives:
Build the category of deprescribing.
Bring integrity back to medicine, where decades of pharmaceutical influence have led to the overprescribing of America.
Operate with high levels of accuracy, integrity and creativity.
Prove that it’s possible to build a massive, profitable company that does right by science and by people.
Build (maybe) the first company that is defined be selling people less stuff.
Outro Health is the first company dedicated to helping people feel better by using less medication, rather than more.
Our flagship program, Taper Management, is a virtual care program that helps people safely taper off antidepressants and other psychiatric medications. It’s based on hyperbolic tapering, the first neurobiology-based method for stopping psychiatric medications.
We’ve built the best team in the budding field of deprescribing, led by our co-founder Dr. Mark Horowitz—the world-leading expert in the space. Dr. Horowitz literally wrote the textbook on deprescribing, and has helped update national guidelines in several countries.
In our first year in market, we've developed a first-of-its-kind care model, generating meaningful revenue with healthy economics, and even establishing research partnerships with leading health systems and universities. The next phase is about model refinement, patient delight, and scale.
More on Outro here:
Our launch in WIRED
Dr. Horowitz on NPR’s Science Friday
What We Do
Outro Health is a digital mental-health company building an evidence-based solution for safely discontinuing psychiatric medications, starting with antidepressants. Its neurobiology-based approach combines individualized tapering plans, clinical support, education, and patient resources to help members transition sustainably off medication. Through affiliated clinical entities, Outro aims to create a more holistic, patient-centered model of mental healthcare that is accessible to people seeking informed medication changes.
